The presenter, along with a guest analyst, discusses three growth stocks suitable for long-term investment. The first pick is Rocket Lab, a speculative space sector stock, but a leader in launches, worth 67.22$. Analyst are rising their price target. The second is AbbVie, a blue chip dividend king, increased 53 years. Emrelis got FDA aproval and might launch in the UK. Two analysts have a target price of 251$. Finally, the third pick is Costco, trading a little under 1000$, it is not splitting stocks, but analysts consider a great buy for the solid return it provides. In summary, analyst see a 10% gain for AbbVie. Also presented a 7 buy and hold stocks.